Ir para o conteúdo
Global sound
Melanoma Matters

Melanoma Matters

Ep 87: INTerpath-001 Press Release - August 2026

· 13 min · Temporada 2 Episódio 87

Notas do episódio

In this episode, Sapna and James discuss the INTerpath-001 press release describing primary endpoint (RFS) and key secondary endpoint (DMFS) findings from the randomized phase 3 study of individualized neoantigen therapy plus pembrolizumab for resected stage IIB to IV melanoma. No data were shared, only descriptive findings of "statistically signficant" and "clinically meaningful" results. As James puts it, one of these is binary, the other is subjective.

Site: podcasters.spotify.com

Ao vivo, última hora: 9.520 músicas em 3.942 rádios de 129 países

Descubra o mundo pelo rádio

Mais formas de descobrir (9)

Ouviu algo legal? Salve ou abra direto no Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
100% NL LiefdeContinuar ouvindo